ConductScience.org, home

Paper17417639

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Holst F and 11 others. Nat Genet, 2007. Cited by 286 papers, by iCite.

Cite this record

ConductScience Library. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Papers, record 17417639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17417639

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
PubMed
Journal
Nat Genet
PubMed
Year
2007
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
286
iCite
Relative citation ratio, by iCite
5.65
iCite
Revised in PubMed
2022-03-16
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Holst FFrederik
2Stahl PRPhillip R
3Ruiz CChristian
4Hellwinkel OOlaf
5Jehan ZZeenath
6Wendland MMarc
7Lebeau AAnnette
8Terracciano LLuigi
9Al-Kuraya KKhawla
10Jänicke FFritz
11Sauter GGuido
12Simon RRonald

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Estrogen Receptor alphaMajor topic
Gene AmplificationMajor topic
Base Sequence
Female
Gene Dosage
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Molecular Sequence Data
Polymerase Chain Reaction
Sequence Analysis, DNA

Source PubMed

Download CSV of topics

Comments and corrections4

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in18583964ESR1 gene amplification in breast cancer: a common phenomenon?https://conductscience.org/library/papers/18583964PubMed
Comment in18583965ESR1 gene amplification in breast cancer: a common phenomenon?https://conductscience.org/library/papers/18583965PubMed
Comment in18583966ESR1 gene amplification in breast cancer: a common phenomenon?https://conductscience.org/library/papers/18583966PubMed
Comment in18583967ESR1 gene amplification in breast cancer: a common phenomenon?https://conductscience.org/library/papers/18583967PubMed

Download CSV of comments and corrections

Cited by168

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 286 citations.

PMIDTitleJournalYearIn PapersSource
42907427Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer.Nat Commun2026https://conductscience.org/library/papers/42907427PubMed
42645071
Quantitative Loop-Mediated Isothermal Amplification (qLAMP) for the Rapid Discrimination of Normal and Cancerous Tissue Models: An Arduino-Based Portable Cancer Detection System Assisted by a pH Microelectrode.
Biosensors (Basel)2026https://conductscience.org/library/papers/42645071PubMed
42591592Beyond the canonical view: steroid receptor network plasticity and mechanosensitive chromatin integration in breast cancer.NAR Cancer2026https://conductscience.org/library/papers/42591592PubMed
41571903
Incorporation of network pharmacology, molecular docking, survival, density functional theory, and experimental studies to explore the potential key targets of formononetin by TERT-mediated anti-cancer effects in MCF-7 breast cancer.
Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41571903PubMed
41155171
Computer-Aided Molecular Design Meets Network Toxicology and Molecular Docking: A Joint Strategy to Explore Common Molecular Mechanisms of Phthalates on Human Breast Cancer and Structure-Activity Relationship.
Int J Mol Sci2025https://conductscience.org/library/papers/41155171PubMed
41062834Efficient and precise inversion of genomic DNA from large to chromosomal scale.Nat Chem Biol2026https://conductscience.org/library/papers/41062834PubMed
39959102Efficient and Explainable Virtual Screening of Molecules through Fingerprint-Generating Networks Integrated with Artificial Neural Networks.ACS Omega2025https://conductscience.org/library/papers/39959102PubMed
39941808Heterogeneity in Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/39941808PubMed
39717718GATA6 in pancreatic cancer initiation and progression.Genes Dis2025https://conductscience.org/library/papers/39717718PubMed
39702552The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer.NPJ Breast Cancer2024https://conductscience.org/library/papers/39702552PubMed
39502314The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis.Front Oncol2024https://conductscience.org/library/papers/39502314PubMed
39329990Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner.Curr Oncol2024https://conductscience.org/library/papers/39329990PubMed
38685777Envisioning Clinical Management of Breast Cancer: a Comprehensive Review.Curr Drug Discov Technol2025https://conductscience.org/library/papers/38685777PubMed
38672654DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care.Cancers (Basel)2024https://conductscience.org/library/papers/38672654PubMed
38643482Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies.Endocrinology2024https://conductscience.org/library/papers/38643482PubMed
38641298Androgen receptor and estrogen receptor variants in prostate and breast cancers.J Steroid Biochem Mol Biol2024https://conductscience.org/library/papers/38641298PubMed
38135758Decoding the basis of histological variation in human cancer.Nat Rev Cancer2024https://conductscience.org/library/papers/38135758PubMed
38066476A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.BMC Cancer2023https://conductscience.org/library/papers/38066476PubMed
37929724Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment.Med Chem2024https://conductscience.org/library/papers/37929724PubMed
37321964LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples.Cancer Rep (Hoboken)2023https://conductscience.org/library/papers/37321964PubMed

See all 168 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17417639

GET https://conductscience.org/api/papers/v1/17417639/cited_by?page=2